JAMA - Journal of the American Medical Association This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Accuracy of Labeling Of Galantamine Generic Drugs And Dietary Supplements
This study examines the accuracy of labeling for galantamine products formulated as both generic drugs and dietary supplements, as well as tests for contamination with microorganisms. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 23, 2024 Category: General Medicine Source Type: research

State Approaches to Stopping Violence Against Health Care Workers
This Viewpoint examines current state-level approaches to addressing the increased incidence of violence against health care workers, as well as how laws are adapting to protect health care personnel. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 22, 2024 Category: General Medicine Source Type: research

Responding Effectively to Disruptive Patient Behaviors
This Viewpoint discusses the use of behavior contracts with patients in response to increasing workplace violence in health care, and highlights the importance of building the evidence base for approaches to dealing with violent behaviors that are effective and just. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 22, 2024 Category: General Medicine Source Type: research

Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition
This cross-sectional study identified the prevalence of patents on risk evaluation and mitigation strategies and their association with delaying generic competition. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 22, 2024 Category: General Medicine Source Type: research

Rural Maternity Care Is in Crisis —Here’s What Could Help
This Medical News article discusses a new report on labor and delivery department closures in the rural US as well as potential financial and workforce solutions. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

CAR T-Cell Therapies Get Boxed Warning for Secondary Cancers
This Medical News article discusses the US Food and Drug Administration ’s new boxed warning requirement and investigation of secondary malignancies after CAR T-cell therapy. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

Clinicians ’ Misperceptions a Barrier to Lifesaving Diarrhea Treatment
Diarrhea is responsible for the deaths of more than 500  000 children aged 5 years or younger every year. Many die from severe dehydration. Oral rehydration salts (ORS), a combination of glucose and salt that is dissolved in clean water, is a highly effective and inexpensive approach to treating dehydration. But even though clinicians in low-resource c ountries recognize that ORS save lives and are the standard of care, few prescribe it to patients. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

Virtual Group Exercise Program Improved Long COVID Symptoms
A group exercise program delivered online in combination with psychological support sessions improved the health-related quality of life for people living with post –COVID-19 condition, also known as long COVID, compared with the usual care of 1 online support session. The results are based on randomized clinical trial data from 585 adults in England and Wales with ongoing physical and mental health symptoms after being hospitalized with SARS-CoV-2. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

Psychedelic Drugs Might Support Sexual Well-Being, Studies Find
People who used psychedelic drugs tended to report better sex and intimacy after their experience, a recent pair of studies published in Scientific Reports found. The first study involved 261 participants who used psychedelics recreationally. The second was a randomized trial that evaluated sexual functioning in 59 people with depression after being treated with psilocybin or a selective serotonin reuptake inhibitor (SSRI). (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

Cancer Risk Decreased 10 Years After Quitting Smoking
People who previously smoked had a lower risk of all types of cancer 10 years after quitting compared with those who currently smoked, according to data from more than 2.9 million adults in Korea. The cancer risk among people who had stopped for at least 15 years was about 50% of the risk of those who continued smoking. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases
Physicians prescribe the antibiotic ciprofloxacin to prevent meningococcal disease among close contacts of people with confirmed illnesses. But cases of meningococcal disease caused by ciprofloxacin-resistant bacteria have risen over the past decade, leading the US Centers for Disease Control and Prevention (CDC) to recently announce new guidance. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

High Lipoprotein(a) May Increase CVD Risk Even Without Inflammation
Previous research has tied high levels of lipoprotein(a) (Lp[a]), a protein that carries cholesterol through the blood, to increased cardiovascular disease (CVD) risk. But the evidence is mixed on whether Lp(a) only raises this risk when there are also increased amounts of inflammation, as measured by high-sensitivity C-reactive protein (hs-CRP) levels in the blood. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

New Antiviral on the Horizon for Mild to Moderate COVID-19
COVID-19 symptoms improved 24 hours sooner among patients with mild to moderate infection who received ensitrelvir, an investigational antiviral drug, than those who received a placebo, according to results from a randomized clinical trial involving more than 1000 patients from Japan, South Korea, and Vietnam. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

Studies to Test How Well PREVENT Predicts Heart Disease in Diverse Groups
Researchers have begun studying how accurately a new tool, known as the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator, estimates risk in people from different racial and ethnic backgrounds as well as from a range of ages, the American Heart Association announced. Three research teams will evaluate the new scores using larger databases and will assess PREVENT ’s fairness and cost-effectiveness compared with the Pooled Cohort Equations (PCEs). (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research

Tirzepatide Lowered Blood Pressure in People With Obesity
People with obesity who received tirzepatide —a glucagon-like peptide 1 (GLP-1) receptor agonist—had lower blood pressure after 9 months compared with those who received a placebo, a study published in Hypertension found. The findings are the latest example of the ways in which GLP-1 receptor agonists might improve cardiometabolic conditio ns that are associated with obesity, the researchers reported. (Source: JAMA - Journal of the American Medical Association)
Source: JAMA - Journal of the American Medical Association - February 21, 2024 Category: General Medicine Source Type: research